Dawsey S M, Wang G Q, Weinstein W M, Lewin K J, Liu F S, Wiggett S, Nieberg R K, Li J Y, Taylor P R
Cancer Prevention Studies Branch, National Cancer Institute, Bethesda, Maryland.
Gastroenterology. 1993 Nov;105(5):1333-40. doi: 10.1016/0016-5085(93)90137-2.
Linxian, China, has one of the highest rates of esophageal cancer in the world. To design a logical biopsy strategy for large-scale endoscopic surveys in Linxian, the aim of this study was to determine whether squamous dysplasia and early squamous cancer are associated with visible lesions that can be targeted for biopsy.
Sixty-three Linxian patients with balloon cytological evidence of squamous dysplasia or early cancer of the esophagus had biopsy specimens taken every 4 cm and additional specimens taken from all visually abnormal areas. The appearance of the 398 biopsy sites was described, and abnormal-appearing areas were photographed. The endoscopic descriptions were then compared with the biopsy diagnoses.
Twenty-five of 31 (81%) moderately dysplastic or worse specimens (including all nine specimens of invasive cancer) came from visually abnormal sites classified as friability, focal red area, erosion, plaque, or nodule. Fifteen of 16 (94%) patients with moderate dysplasia or worse biopsy diagnoses would have been identified if only these visible target lesions had been sampled.
For surveillance in this high-risk population, random biopsy specimens may be unnecessary; sampling the target lesions described appears sufficient to detect nearly all invasive cancer and most dysplasia. Awareness of these lesion appearances may also aid in earlier detection of squamous cancers of the esophagus in lower-risk populations such as those in Europe and North America.
中国林县是世界上食管癌发病率最高的地区之一。为了设计一种适用于林县大规模内镜检查的合理活检策略,本研究的目的是确定鳞状上皮发育异常和早期鳞状细胞癌是否与可作为活检靶点的可见病变相关。
63例林县患者经气囊细胞学检查证实有食管鳞状上皮发育异常或早期癌,并每隔4厘米取活检标本,同时从所有视觉上异常的区域额外取材。描述了398个活检部位的外观,并对外观异常的区域进行拍照。然后将内镜描述与活检诊断结果进行比较。
31例(81%)中度发育异常或更严重的标本(包括所有9例浸润癌标本)中有25例来自视觉上异常的部位,这些部位被分类为易碎、局灶性红色区域、糜烂、斑块或结节。如果仅对这些可见的目标病变进行取样,16例活检诊断为中度发育异常或更严重的患者中有15例(94%)能够被识别出来。
对于这一高危人群的监测,随机活检标本可能是不必要的;对所描述的目标病变进行取样似乎足以检测出几乎所有的浸润癌和大多数发育异常。了解这些病变外观也可能有助于在欧洲和北美等低风险人群中更早地发现食管鳞状细胞癌。